Next, we examine the relationship between CRGPI and HLA family genes and known predictive biomarkers for immunotherapy, such as immune checkpoint gene expression (PD1, PD-L1), TMB, MSI-H, and tumor-infiltrating lymphocyte (TIL) numbers 42, 43. Here, PDCD1 is linked to neoplasm.